Global Mitomycin C Market Survey and Trend Research 2018

January 2018 | 85 pages | ID: G1193136AAAEN
99Strategy

Abstracts

Summary

Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Kyowa-kirin, Intas Pharmaceuticals, Teva, Bristol-Myers Squibb, Speciality European Pharma, Speciality European Pharma, Alkem Laboratories, Varifarma, APOGEPHA etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Mitomycin C Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 MITOMYCIN C MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Kyowa-kirin (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Intas Pharmaceuticals (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Teva (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Speciality European Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Speciality European Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Alkem Laboratories (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Varifarma (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 APOGEPHA (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL MITOMYCIN C MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Mitomycin C Market 2012-2017, by Type, in Volume
Table Global Mitomycin C Market Forecast 2018-2023, by Type, in USD Million
Table Global Mitomycin C Market Forecast 2018-2023, by Type, in Volume
Table Kyowa-kirin Overview List
Table Mitomycin C Business Operation of Kyowa-kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Overview List
Table Mitomycin C Business Operation of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Mitomycin C Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Mitomycin C Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Speciality European Pharma Overview List
Table Mitomycin C Business Operation of Speciality European Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Speciality European Pharma Overview List
Table Mitomycin C Business Operation of Speciality European Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alkem Laboratories Overview List
Table Mitomycin C Business Operation of Alkem Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Varifarma Overview List
Table Mitomycin C Business Operation of Varifarma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table APOGEPHA Overview List
Table Mitomycin C Business Operation of APOGEPHA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Mitomycin C Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Mitomycin C Sales Revenue Share, by Companies, in USD Million
Table Global Mitomycin C Sales Volume 2012-2017, by Companies, in Volume
Table Global Mitomycin C Sales Revenue Share, by Companies in 2017, in Volume
Table Mitomycin C Demand 2012-2017, by Application, in USD Million
Table Mitomycin C Demand 2012-2017, by Application, in Volume
Table Mitomycin C Demand Forecast 2018-2023, by Application, in USD Million
Table Mitomycin C Demand Forecast 2018-2023, by Application, in Volume
Table Global Mitomycin C Market 2012-2017, by Region, in USD Million
Table Global Mitomycin C Market 2012-2017, by Region, in Volume
Table Mitomycin C Market Forecast 2018-2023, by Region, in USD Million
Table Mitomycin C Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Mitomycin C Industry Chain Structure
Figure Global Mitomycin C Market Growth 2012-2017, by Type, in USD Million
Figure Global Mitomycin C Market Growth 2012-2017, by Type, in Volume
Figure Global Mitomycin C Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Mitomycin C Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region